Effect of transurethral resection on urinary quality of life after permanent prostate brachytherapy

International Journal of Radiation Oncology Biology Physics

Volumn 58, Issue 1, 2004, Pages 81-88

  Merrick, Gregory S ^a,b   Butler, Wayne M ^a,b   Wallner, Kent E ^c   Galbreath, Robert W ^a,b  

^a WHEELING HOSPITAL   (United States)

^b WHEELING JESUIT UNIVERSITY   (United States)

^c DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

Brachytherapy; Prostate; Quality of life; TURP; Urinary morbidity

Indexed keywords

ANTIGENS; DOSIMETRY; RADIOTHERAPY; REGRESSION ANALYSIS; TUMORS;

BRACHYTHERAPY;

ONCOLOGY;

ISOTOPE; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CATHETER; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DOSIMETRY; FOLLOW UP; HUMAN; HYPERTENSION; LINEAR REGRESSION ANALYSIS; MALE; MULTIVARIATE ANALYSIS; ORGAN SIZE; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; QUALITY OF LIFE; SCORING SYSTEM; SYMPTOMATOLOGY; TOBACCO; TRANSURETHRAL RESECTION; URINARY DYSFUNCTION;

EID: 0347624517     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(03)00776-4     Document Type: Article

References (31)

1. Merrick G.S., Wallner K.E., Butler W.M. Permanent interstitial brachytherapy in the management of carcinoma of the prostate gland. J Urol. 169:2003;1643-1652.
2. Merrick GS, Wallner KE, Butler WM. Minimizing prostate brachytherapy-related morbidity. Urology 2003;62:786-792.
3. Lee W.R., McQuellon R.P., Case L.D., et al. Early quality of life assessment in men treated with permanent source interstitial brachytherapy for clinically localized prostate cancer. J Urol. 162:1999;403-406.
4. Lee W.R., McQuellon R.P., Harris-Henderson K., et al. A preliminary analysis of health-related quality of life in the first year after permanent source interstitial brachytherapy (PIB) for clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 46:2000;77-81.
5. Lee W.R., Hall M.C., McQuellon R.P., et al. A prospective quality-of-life study in men with clinically localized prostate carcinoma treated with radical prostatectomy, external beam radiotherapy, or interstitial brachytherapy. Int J Radiat Oncol Biol Phys. 51:2001;614-623.
6. Brandeis J.M., Litwin M.S., Burnison C.M., et al. Quality of life outcomes after brachytherapy for early stage prostate cancer. J Urol. 163:2000;851-857.
7. Davis J.W., Kuban D.A., Lynch D.F., et al. Quality of life after treatment for localized prostate cancer Differences based on treatment modality . J Urol. 166:2001;947-952.
8. Wei J.T., Dunn R.L., Sandler H.M., et al. Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. J Clin Oncol. 20:2002;557-566.
9. Merrick G.S., Butler W.M., Wallner K.E., et al. Long-term urinary quality of life following permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys. 56:2003;454-461.
10. Blasko J.C., Ragde H., Grimm P.D. Transperineal ultrasound-guided implantation of the prostate Morbidity and complications . Scand J Urol Nephrol Suppl. 137:1991;113-118.
11. Wallner K., Blasko J., Dattoli M.J. Prostate brachytherapy made complicated. 2nd ed :2002;p. 15.1 SmartMedicine Press, Seattle, WA. 15.21.
12. Talcott J.A., Clark J.A., Stark P.C., et al. Long-term treatment related complications of brachytherapy for early prostate cancer A study of patients previously treated . J Urol. 166:2001;494-499.
13. Stone N.N., Ratnow E.R., Stock R.G. Prior transurethral resection does not increase morbidity following real-time ultrasound-guided prostate seed implantation. Tech Urol. 6:2000;123-127.
14. Wallner K., Lee H., Wasserman S., et al. Low risk of urinary incontinence following prostate brachytherapy in patients with a prior transurethral resection. Int J Radiat Oncol Biol Phys. 37:1997;565-569.
15. Hu K., Wallner K.E. Urinary incontinence in patients who have a TURP/ TUIP following prostate brachytherapy. Int J Radiat Oncol Biol Phys. 40:1998;783-786.
16. Terk M.D., Stock R.G., Stone N.N. Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate. J Urol. 160:1998;1379-1382.
17. Wei J.T., Dunn R.L., Litwin M.S., et al. Development and validation of the Expanded Prostate Cancer Index Composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology. 56:2000;899-905.
18. Barry M.J., Fowler F.J., O'Leary M.P., et al. The American Urological Association symptom index for benign prostatic hypertrophy. J Urol. 148:1992;1549-1557.
19. Merrick G.S., Butler W.M., Farthing W.H., et al. The impact of Gleason score accuracy as a criterion for prostatic brachytherapy patient selection. J Brachyther Int. 14:1998;113-121.
20. Merrick G.S., Butler W.M. Modified uniform seed loading for prostate brachytherapy Rationale, design and evaluation . Tech Urol. 6:2000;78-84.
21. Butler W.M., Merrick G.S., Lief J.H., et al. Comparison of seed loading approaches in prostate brachytherapy. Med Phys. 27:2000;381-392.
22. Nath R., Anderson L.L., Luxton G., et al. Dosimetry of interstitial brachytherapy sources Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43 . Med Phys. 22:1995;209-234.
23. Butler W.M., Merrick G.S., Dorsey A.T., et al. Comparison of dose length, area, and volume histograms as quantifiers of urethral dose in prostate brachytherapy. Int J Radiat Oncol Biol Phys. 48:2000;1575-1582.
24. Litwin M.S., Lubeck D.P., Henning J.M., et al. Differences in urologist and patient assessments of health related quality of life in men with prostate cancer Results of the CapSure database . J Urol. 159:1998;1988-1992.
25. Merrick G.S., Butler W.M., Lief J.H., et al. Permanent prostate brachytherapy Acute and late toxicity . J Brachyther Int. 17:2001;229-236.
26. Foote J., Yun S., Leach G.E. Postprostatectomy incontinence Pathophysiology, evaluation, and management . Urol Clin North Am. 18:1991;229-241.
27. Krupski T., Petroni G.R., Bissonette E.A., et al. Quality-of-life comparison of radical prostatectomy and interstitial brachytherapy in the treatment of clinically localized prostate cancer. Urology. 55:2000;736-742.
28. Wallner K., Merrick G., True L., et al. I-125 vs. Pd-103 for low-risk prostate cancer Morbidity outcomes from a prospective randomized multicenter trial . Cancer J. 8:2002;67-73.
29. Ghaly M., Wallner K., Merrick G., et al. Brachytherapy versus brachytherapy plus beam radiation for prostate cancer Morbidity outcomes from two prospective randomized multicenter trials . Int J Radiat Oncol Biol Phys. 55:2003;1288-1293.
30. Han B.H., Demel K.C., Wallner K., et al. Patient reported complications after prostate brachytherapy. J Urol. 166:2001;953-957.
31. Stone N.N., Stock R.G. Complications following permanent prostate brachytherapy. Eur Urol. 41:2002;427-433.